Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.

In many countries, Kaposi's sarcoma (KS) is the commonest malignancy among individuals infected with the human immunodeficiency virus-1 (HIV) and is a cause of substantial morbidity and mortality.